View This Report »
Get Industry Insights. Simply.
Talk to Veronica
+1 718 514 2762
Refractory patients, niche indication expansions, and geographical reach offer room for growth in an otherwise crowded epilepsy market. This report addresses the following questions: - Why do leading antiepileptic ...
The global epilepsy drugs market is expected to reach over USD 5,474.14 million by 2024, according to a new report by Grand View Research, Inc. The rising government funding for the development of new ...
Metabotropic Glutamate Receptor 5 (mGluR5 or GRM5 or GPRC1E or MGLUR5) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Metabotropic Glutamate Receptor 5 (mGluR5 or GRM5 or GPRC1E or MGLUR5) ...